Rekvina Laboratories Limited (VINRKLB.BO)
BSE · INR · Healthcare · Drug Manufacturers - Specialty & Generic
₹60.66 (+4.48%) as of
Key statistics
- Market cap
- 674.28M
- EPS (TTM)
- -0.57
- Dividend yield
- 0.00%
- 52-week range
- 4.50 – 65.07
- Beta
- 0.63
- Revenue (TTM)
- 19.34M
- Profit margin
- -17.57%
- Volume
- 3.60k
About Rekvina Laboratories Limited
Rekvina Laboratories Limited engages in manufacturing and marketing pharmaceutical products and related activities in India. It offers pharmaceutical formulations. The company also provides contract research and manufacturing services. In addition, it offers lab supplies, custom solutions, chemical reagents, gynecology, surgical therapeutics, pediatrics, dermatology, and products. Rekvina Laboratories Limited was incorporated in 1988 and is based in Vadodara, India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Vadodara, India
- Employees
- 5
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.